“My team and I experienced first-hand the limitations of the current standard of care for understanding and treating arrhythmias,” David Krummen, MD, cardiac electrophysiologist at UC San Diego Health and professor of medicine at University of California San Diego School of Medicine, said in a prepared statement.
Krummen co-invented vMap and serves as clinical advisor to the company that developed the technology, Vektor Medical.
“We designed vMap to improve ablation outcomes by rapidly providing arrhythmia source information to the physician,” he said. “We want this technology to increase first-pass ablation success, decrease procedural risk, and improve the care of patients with heart rhythm abnormalities.”
vMap received FDA clearance in November 2021. The system converts ECG data into 2D and 3D arrhythmia source maps using data leveraged from millions of arrhythmia simulations performed by technology resources, including the UC San Diego’s San Diego Supercomputer Center.
The results from vMap’s first clinical study will be published later in 2022.
Find more EP lab technology news
No comments:
Post a Comment